Portal de Periódicos da CAPES

Tardive dyskinesia associated with fluoxetine

1996; American Psychiatric Association; Volume: 47; Issue: 9 Linguagem: Inglês

10.1176/ps.47.9.991

1557-9700

Steven Dubovsky, M. Albert Thomas,

Botulinum Toxin and Related Neurological Disorders

Back to table of contents Previous article Next article No AccessTardive dyskinesia associated with fluoxetinePublished Online:1 Apr 2006https://doi.org/10.1176/ps.47.9.991AboutSectionsView articleAbstractPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail View articleAbstractThree cases in which patients who were taking fluoxetine for relief of depression showed patterns of abnormal movements suggestive of tardive dyskinesia are presented. In the first case, abnormal facial movements began four weeks after fluoxetine was added to doxepin and lithium and remitted after fluoxetine was discontinued. In the second case, abnormal movements of the mouth and hands were noticed four years after the patient started taking fluoxetine and continued to be present a year after withdrawal of the medication. In the third case, orofacial dyskinesia that had remitted after withdrawal of sertraline and paroxetine and reappeared with fluoxetine was still present eight months after fluoxetine was withdrawn. Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - Psychiatric Services $35.00 Add to cart PPV Articles - Psychiatric Services Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited byDrug-induced tardive dyskinesia21 February 2020 | Neurology, Neuropsychiatry, Psychosomatics, Vol. 12, No. 1Tardive Dyskinesia: Treatment Update16 August 2019 | Current Neurology and Neuroscience Reports, Vol. 19, No. 9Drugs & Aging, Vol. 35, No. 11Journal of the Neurological Sciences, Vol. 389Duloxetine-Associated Tardive Dyskinesia Resolved With FluvoxamineJournal of Clinical Psychopharmacology, Vol. 32, No. 5General Hospital Psychiatry, Vol. 32, No. 6Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 33, No. 2The World Journal of Biological Psychiatry, Vol. 10, No. 4-3Current Opinion in Psychiatry, Vol. 22, No. 1The Journal of Clinical Pharmacology, Vol. 48, No. 3Biological Psychiatry, Vol. 50, No. 2American Journal of Medical Genetics, Vol. 96, No. 6Journal of Clinical Psychopharmacology, Vol. 20, No. 6CNS Drugs, Vol. 14, No. 5Selective Serotonin-Reuptake Inhibitor–Induced Movement Disorders26 June 2016 | Annals of Pharmacotherapy, Vol. 32, No. 6SSRI-Induced extrapyramidal side-effects and akathisia: implications for treatment1 July 2016 | Journal of Psychopharmacology, Vol. 12, No. 2Extrapyramidal Reactions and the Selective Serotonin-Reuptake Inhibitors28 June 2016 | Annals of Pharmacotherapy, Vol. 31, No. 12Reactions Weekly, Vol. &NA;, No. 622 Volume 47Issue 9 September 1996Pages 991-993 Metrics PDF download History Published online 1 April 2006 Published in print 1 September 1996